ArticleMedicina (Kaunas, Lithuania)2022

Clinical Study of Serum Serotonin as a Screening Marker for Anxiety and Depression in Patients with Type 2 Diabetes.

Lavinia-Alexandra Moroianu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.